Your privacy is important to us. Any information which you provide about yourself or any third party will be used by Candela Capital in accordance with applicable data protection laws.
When you visit this site Candela Capital does not collect any personal identifying information about you. We do not use individual information for commercial purposes. You will not receive any email from Candela Capital simply as a result of visiting our site.
Candela Capital may, in connection with its business dealings with clients and other third parties, hold certain limited personal information on individuals within these organisations. Examples of such information may include name, email address, phone number and other information relevant to our business. Where such information is held by Candela Capital it is held solely for the purpose of conducting our legitimate business.
The personal data held may be stored at a destination outside the EEA. Candela Capital takes all steps reasonably necessary to ensure that personal data is treated securely and in accordance with this privacy notice. Any personal data collected will be retained for as long as necessary to fulfil the purposes for which it has been collected or as required by law.
Candela Capital is committed to protecting information held, including through the use of physical, electronic and procedural safeguards.
You may contact the company if you wish to receive further information on this.
Candela Capital is authorised and regulated by the Financial Conduct Authority (FRN No. 228816). Regulated in England and Wales.
In the United States of America we offer securities through XT Capital Partners, LLC. Finra/SIPC
NeoMed V €150m Global Life Science............Stafford Timberland V €155m Global Timber............Gemini III $200m Global Oil & Gas............Edmond de Rothschild Investment Partners €250m French Development Capital............Palatine Fund II £150m UK Buy-Out............Jadeberg III €125m DACH Technology Growth Capital